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Medical travel has the capacity to counter increasing costs of health care by creating new 
markets and increased revenue for health services, potentially benefiting local popula-
tions, economies, and health-care systems. This paper is part of a broad, comprehensive 
project aimed at developing a global health access policy (GHAP). It presents key issues 
to consider in terms of ensuring economic viability, sustainability, and limiting risk to 
the many stakeholders involved in the rapidly expanding industry of medical travel. The 
noted economic and legal barriers to medical travel are based on a synthesis of themes 
found in an extensive review of the available literature. Economic considerations, when 
setting up a GHAP, include a dynamic approach to pricing that is fair to the local popu-
lation. Legal considerations include the implementation of international quality standards 
and the protection of the rights of those traveling as well as those of local populations 
in recipient countries. By taking into account these opportunities, the GHAP will more 
adequately address existing gaps in the economic and legal regulation of medical travel.
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iNtrODUctiON
In contrast to medical tourism, which broadly describes the movement of individuals for non-urgent 
treatments (e.g., cosmetic surgeries) or recreational and leisure purposes (1), the definition of medical 
travel explicitly refers to patients crossing national borders with the purpose of receiving treatment 
that has been determined as essential to maintaining quality of life by a health professional, but may 
not need to be performed urgently (2). The work reported in this paper is part of a broad, comprehen-
sive project aimed at developing a global health access policy (GHAP) to facilitate safety, efficiency, 
and equal access in medical travel, as outlined by the Organisation for Economic Co-operation and 
Development (OECD) in the context of medical tourism (1). This work establishes the economic 
and legal perspective of a GHAP, identifying the key issues to consider when setting up such a policy 
to ensure economic viability and sustainability, as well as limiting risk to the stakeholders involved.
An increase in medical travel might result in a broad spectrum of consequences, e.g., (a) a wide-
ranging impact on health-care systems (3, 4), (b) access of inbound countries (countries which receive 
medical travelers) to a larger market and additional revenue streams (5), and (c) easier access of patients 
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in outbound countries (countries which send medical travelers) to 
medical care, reduced costs, and better standard of care (1). However, 
the uncontrolled movement of patients carries significant risks for 
both patients and health-care systems with respect to quality stand-
ards, dissemination of diseases, financial implications of adverse 
events, and unregulated developments on the health-care market 
(6, 7). Accordingly, the costs and benefits of medical travel as 
well as associated ethical and legal concerns call for a systematic 
evaluation to ensure the economic viability and sustainability of 
medical travel.
Several agreements that focus on facilitating medical travel 
already exist in certain regions, including those between the EU 
member states (8), within North America (NAFTA), and between 
OECD members such as the United States and Korea (1). For 
example, the EU’s Patients’ Rights Directive supports policies 
within the EU that ensures that patients making use of medical 
services abroad are entitled to receive financial reimbursements 
and follow-up care in their home country (8). However, this is 
still a directive and not regulation, and therefore, the extent to 
which financial support is given can differ for each member state. 
Furthermore, the existing frameworks often fail to consider the 
much wider needs of patients traveling for care, such as protection 
and indemnification, psychosocial support during rehabilitation 
and long-term liability, as well as ensuring access and equity (7, 9). 
Globally, therefore, medical travel remains a widely unregulated 
extension of health care (10).
As such, GHAP seeks to address existing gaps in the regula-
tion of medical travel. There is a need for more evidence-based, 
patient-centered, and population-centered frameworks ensuring 
positive outcomes for all stakeholders, accounting for potential 
areas of increased risk and improving sustainability and equity. 
In the following section, we focus on the economic and legal 
considerations required for the development of such frameworks.
cONseQUeNces AND cONcerNs OF 
MeDicAL trAveL
This paper focuses on the economic and legal consequences of 
medical travel (specified earlier as essential and non-cosmetic 
care), from the moment a patient starts to consider the option of 
medical travel, through receiving treatment and posttreatment 
care, to returning to the outbound country. Our aim was twofold: 
first, to broadly identify from existing literature the economic 
and legal risks of medical travel, given its aforementioned global 
increase, and second, to synthesize these risks and provide key 
considerations on how to establish a legal and economic frame-
work for medical travel. We note that we did not intend to provide 
a full breakdown of the costs and benefits of medical travel as 
this was out of scope of our project and not justified by our broad 
literature search. A non-systematic review of scientific and gray 
literature was conducted. Articles were considered if they were 
found in any of the six databases under the terms “medical tour-
ism” or “medical travel” since the year 2000, with no language 
restrictions. The databases used were PubMed, EconLit, Google 
Scholar, the World Bank research database, Europe PubMed 
Central, and EMBASE.
We first identified primary themes to be reviewed through 
common arguments used in high-quality sources as well as 
through common topics in low-quality or potentially very biased 
material. Papers were included if they provided specific data, 
policy or practice analyses, or substantial insight to key themes, 
regarding travel for necessary care. This approach was used to 
identify primary themes related to economic or legal considera-
tions presented in available literature. Themes identified by the 
authors are part of a larger study examining medical travel in 
which various themes relating to medical travel were identified 
(2). Despite the existence of themes relating to economic and 
legal frameworks found in the literature, overall, we found that 
there had been no approach to synthesize this information to 
specifically inform a GHAP. We have, therefore, summarized 
the key considerations for establishing an economic and legal 
framework for GHAP, based on the themes identified. While 
taking into account that this is a non-exhaustive compilation of 
proposals, the current work provides the first step toward the 
development of an economic and legal framework for medical 
travel (such as GHAP).
economic Opportunities and 
considerations
Medical travel may provide numerous financial incentives for 
health-care systems and travelers alike. In inbound countries, 
attracting medical travelers can serve as a mechanism to gener-
ate additional revenue (11). The resulting higher utilization of 
resources, such as hospitals and technical equipment, can contrib-
ute to cost reduction in health-care delivery (12). Furthermore, 
medical travel has the potential to contribute to economic growth 
through the creation of local job opportunities (13). A study in 
India investigated the effects of medical travel on the local popula-
tion and highlighted benefits with regards to enhanced economic 
growth, revserse brain drain, and the increased investment in 
medical technologies and training (14). To further maximize the 
benefits for the local population, tax revenues accrued through 
linkages with tourism, insurance, food, and hotel business (12) 
could be allocated to the hospitals and health-care systems for 
domestic patients (15). Singapore and Cuba are useful examples, 
since the involvement of the respective countries in medical 
tourism, according to local authorities, has generated income 
benefiting the local population (16, 17). There is also evidence to 
suggest that due to the requirement to comply with international 
quality standards of care, there has been a trickle-down effect in 
inbound countries in terms of skills, technologies, and improved 
quality standards (1, 14). Finally, a liberalization of the market 
can exert competitive pressure on local health-care providers 
and consequently drive down costs by encouraging economies to 
maximize their comparative advantage (5).
Medical travel also has the capacity for negative financial con-
sequences. A significant source of financial concern results from 
complications associated with medical treatment abroad (7). The 
potential spread of disease due to the unregulated movement of 
patients can create significant burden on national health systems 
and insurance companies (6). Another source of concern is that 
resources are primarily invested into private hospitals addressing 
tABLe 1 | economic opportunities and risks for medical travel and 
suggested framework elements.
inbound countries
Opportunities suggested framework elements
1.  Generate additional revenue for 
domestic health-care system
Tax policies to subsidize local health 
system
2. Create job opportunities Flexible approach to pricing in 
inbound countries
3.  Tax revenue sharing with domestic 
health-care system
Accrue tax revenues via hotel,  
food, etc.
risks suggested framework elements
1.  Spread of disease due to unregulated 
movement of patients
Improved quality standards
2.  The development of an inequitable,  
two-tiered health system
See inbound opportunities 1 and 3
Outbound countries
Opportunities suggested framework elements
1.  Residents can seek out treatment 
that is costly/unavailable
Involvement/engagement in a 
GHAP
2. Increased availability of specialists Facilitating more efficient division of 
labor and knowledge
risks suggested framework elements
1.  Decreased revenue as a result of 
patients traveling abroad
See outbound opportunities 1 
and 2
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the need of paying medical travelers, resulting in an inequitable 
two-tiered health system (12, 15, 18). For the local population, 
this can contribute to rising prices and limited access to health 
services (12, 15). This phenomenon is seen in Thailand, where 
a significant number of locals are unable to afford medical care 
in the private sector as a consequence of artificially high prices 
targeted toward medical travelers (19). Moreover, it may lead 
to understaffing of the local sector and increased strain on the 
public-care providers (14). Furthermore, increase in number of 
high-income patients traveling abroad for care may result in a 
decrease in revenue in the outbound country, as well as decline 
in political support for investment and development in local 
facilities and technology (20). Outbound countries may also have 
some obligation to subsidize medical travelers from their country, 
as outlined in the EU’s Patients’ Rights Directive (8).
Key elements for an economic Framework
Based on the factors outlined in the previous section, Table  1 
summarizes the economic risks, opportunities, and suggested 
key elements in the medical travel context. First, inbound 
countries must focus on limiting the rise of two-tiered systems. 
For example, a tax policy could be introduced to health-care 
providers, which would subsidize the local health-care system. 
Another solution could entail a flexible approach to pricing of 
medical procedures. Such interventions would support the local 
health infrastructure and limit the impact of market mechanisms, 
which otherwise poses disadvantages to local populations due to 
the increasing prices (21). Furthermore, establishing a solid eco-
nomic framework could stimulate competition within inbound 
countries, which might subsequently result to lower domestic 
prices. In outbound countries, ensuring that medical travelers are 
reimbursed for the cost of treatment may increase access to medi-
cal care for patients (Verra et al., in review), as well as facilitate 
follow-up care in the traveler’s home country.
Legal Opportunities and considerations
In order to protect patients and reduce the financial burden on 
health systems, regulatory oversight needs to be established for 
each step within the medical travel process. Regarding the early 
stages of the medical travel process (exploration and planning 
phases), legal and ethical considerations include providing 
information for patients, which now includes the booming 
market of third-party agencies, mediating between patients and 
prospective medical centers. Such organizations vary in terms 
of comprehensiveness of service but generally finalize travel 
arrangements, liaise with the clinics abroad, and make follow-up 
arrangements (22). As they often function as the first point of 
contact for patients, they play a significant role as information 
provider. Currently, there are no regulations in place to monitor 
the type and reliability of information provided by the third-party 
agencies, which has led to a market operating in a “regulatory 
vacuum” (23).
Several studies report shortcomings regarding the communi-
cation of medical information and records in the treatment and 
follow-up stages of travel (24, 25), as well as substandard follow-
up care and social support (26, 27). Although the Patients’ Rights 
Directive, in theory, requires that all EU member states provide 
follow-up care (8), research shows that, in practice, physicians 
are frequently unaware of this requirement (28), and additional 
binding requirements to ensure continuity of care are not in place 
(9). There is also no consensus on international quality standards, 
which aim to reduce the differences in the quality level of treat-
ment and hospital facilities (15, 20, 29, 30). As a consequence, 
there is a greater risk for the transmission of disease as well as the 
risk of complications pre- and postmedical treatment (9).
Key elements for a Legal Framework
With medical travelers moving across the world, it is imperative to 
establish a legal framework clearly outlining responsibilities and 
liabilities for each step of the medical travel process, especially 
with regards to transitions such as follow-up care and adverse 
events. Table  2 summarizes the legal risks, opportunities, and 
suggested key elements in the medical travel context. Given the 
broad nature of these considerations and the inclusion of patient 
safety and well-being considerations, we note that these include 
some ethical elements but have given them the general term 
“legal” considerations. Of particular importance throughout 
the entire medical travel process should be the definition and 
implementation of internationally standardized minimum qual-
ity standards (30). This process should encompass an external 
evaluation and associated accreditation program to ensure that 
health-care facilities comply with minimum standards (23). In 
order to avoid the emergence of various accrediting bodies and 
discrepancies in the accreditation process, the establishment of 
an international authority would be necessary to oversee the 
process (for instance, the International Society for Quality in 
Healthcare) (31). Due to the rapidly developing market of third-
party agencies, there is an urgent call for an establishment and 
tABLe 2 | Legal opportunities and risks for medical travel and suggested 
framework elements.
inbound countries
Opportunities suggested framework elements
1.  Adherence to international quality 
standards
Involvement/engagement in a GHAP
2.  Provision of social support during 
treatment process
risks suggested framework elements
1.  Incorrect communication of medical 
information
Guidelines regarding handling of 
patient data
2.  Discrepancies in international quality 
standards
Establishment of an authority to 
oversee standards process
Outbound countries
Opportunities suggested framework elements
1.  Standardization of services provided 
by third-party agencies
Involvement/engagement in a GHAP
2. Continuity of care Implementation of guidelines that 
ensure follow-up care
risks suggested framework elements
1.  Financial implications of adverse 
events and unregulated developments
Outlined responsibilities for each 
step of medical travel
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maintenance of quality standards in the domain of third-party 
health-care providers (30).
In order to facilitate the treatment process and prevent com-
plications, the communication of medical information is a key 
element to consider in the development of a legal framework. 
A failure to transmit medical notes to the treating center abroad 
could be avoided by the use of a common online platform for 
health-care staff and patients. This platform could be utilized for 
medical communication as well as transfer of medical records 
(32). Regulations should outline requirements in terms of han-
dling of sensitive patient data and risk communication (33).
Additionally, legal frameworks focused on the provision of 
social support need to be considered both during the treatment 
and follow-up processes. Social support can decrease stress, 
improve patients’ well-being while traveling, and improve the 
recovery process (34, 35). With this in mind, the definition of 
juridical facilitation of travel arrangements could be of great 
benefit to medical travelers. This could entail the provision of 
subsidies for costs of an accompanying significant other, as well 
as less stringent visa procedures, when accompanying a relative 
during the medical travel process.
cONcLUDiNG reMArKs
The implementation of a GHAP is crucial to ensure safe and 
economically beneficial medical travel for a broader population. 
In inbound countries, the promotion of medical travel has the 
capacity to counter increasing costs of health care by creating new 
markets and increased revenue for health services, and lead to 
more efficient use of resources and labor benefiting local popula-
tions, economies, and health-care systems. In outbound countries, 
medical travel can provide access to treatment that is more afford-
able or unavailable domestically. Further, legal consequences 
must be considered at each phase of the medical travel process. 
Legal considerations include the standardization of visa proce-
dures, the implementation of international quality standards, the 
accreditation of health-care providers and third-party agencies, 
the protection of the local population, and the monitoring of 
information provided to patients to ensure informed decision 
making for the patients and the families involved. Fairness, equal 
access to treatments for medical travelers and local populations, 
equity, and long-term sustainability are key components when 
developing a GHAP framework. Considering the existing risk for 
all stakeholders, it is essential that existing economic and legal 
barriers to medical travel are accounted for in the establishment 
of a comprehensive GHAP.
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